- 同花顺特色产品
- 〈高级诊股〉全方位深度分析，提供明确投资建议
- 〈舆情监控〉实时监控个股情报
- 短期趋势：
强势上涨过程中，可逢低买进，暂不考虑做空。
- 中期趋势：
正处于反弹阶段。
- 长期趋势：
迄今为止，共48家主力机构，持仓量总计5783.39万股，占流通A股24.61%
- 波段诊断：
-
技术面诊股
诊断结果：6.4技术面打败了80%的股票
技术面评分前10的股票
近期的平均成本为66.75元，股价在成本上方运行。空头行情中，目前正处于反弹阶段，投资者可适当关注。
平均成本
近期的平均成本为66.75元，股价在成本上方运行。
[{"text":"\u5e73\u5747\u6210\u672c","value":"66.75","date":1610613192,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势接近大盘，跑赢行业平均水平。
[{"date":"2021.01.15","stock":"1.20","trade":"1.20","ind":"0.01"},{"date":"2021.01.14","stock":"6.54","trade":"1.00","ind":"-0.91"},{"date":"2021.01.13","stock":"0.08","trade":"-2.33","ind":"-0.27"},{"date":"2021.01.12","stock":"1.83","trade":"0.33","ind":"2.18"},{"date":"2021.01.11","stock":"2.17","trade":"-2.00","ind":"-1.08"},{"date":"2021.01.08","stock":"-3.06","trade":"-0.13","ind":"-0.17"},{"date":"2021.01.07","stock":"0.00","trade":"-3.11","ind":"0.71"},{"date":"2021.01.06","stock":"-1.21","trade":"-0.74","ind":"0.63"},{"date":"2021.01.05","stock":"-5.52","trade":"0.33","ind":"0.73"},{"date":"2021.01.04","stock":"-0.11","trade":"0.10","ind":"0.86"},{"date":"2020.12.31","stock":"3.52","trade":"1.35","ind":"1.72"},{"date":"2020.12.30","stock":"-0.93","trade":"-0.35","ind":"1.05"},{"date":"2020.12.29","stock":"-1.64","trade":"-0.62","ind":"-0.54"},{"date":"2020.12.28","stock":"-1.12","trade":"-1.62","ind":"0.02"},{"date":"2020.12.25","stock":"0.06","trade":"0.28","ind":"0.99"},{"date":"2020.12.24","stock":"0.06","trade":"-2.60","ind":"-0.57"},{"date":"2020.12.23","stock":"0.35","trade":"-1.29","ind":"0.76"},{"date":"2020.12.22","stock":"-3.82","trade":"-0.71","ind":"-1.86"},{"date":"2020.12.21","stock":"6.39","trade":"0.30","ind":"0.76"},{"date":"2020.12.18","stock":"-2.43","trade":"-1.49","ind":"-0.29"},{"date":"2020.12.17","stock":"-9.80","trade":"1.37","ind":"1.13"}]
司太立,上证指数,化学制药指数
压力支撑
该股压力位为66.73元，支撑位为64.25元。
[{"text":"\u538b\u529b\u4f4d","value":"66.73","date":1610640000,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"64.25","date":1610640000,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前正处于反弹阶段，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：6.7资金面打败了96%的股票
主力控盘前10的股票
行业资金
化学制药行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：01月15日 20:32
| 机构今日流向(万元) | -438.19 | 机构5日流向(万元) | -4970.62 |
| 机构10日流向(万元) | -9909.25 | 机构20日流向(万元) | -17499.66 |
机构持仓
2020-09-30 与 2020-06-30 相比，主力机构持仓量减少2876.94万股，其中基金净增仓15家，主力净减仓172家，暂未发现中长期投资价值。
截止2020-09-30，共48家主力机构（基金44家，券商集合理财1家，信托公司1家，一般法人2家），持仓量总计5783.39万股，占流通A股24.61%
其中，基金持仓与2020-06-30相比：
增仓：21家 ，增持 527.58万股
减仓：6家 ，减持 20.17万股
新出现在主力名单中：18家 ，持有1076.42万股
从主力名单中消失：190家 ，原持有3985.66万股
其中，基金持仓与2020-06-30相比：
增仓：21家 ，增持 527.58万股
减仓：6家 ，减持 20.17万股
新出现在主力名单中：18家 ，持有1076.42万股
从主力名单中消失：190家 ，原持有3985.66万股
消息面诊股
诊断结果：5.5消息面打败了82%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 司太立限售解禁特别提示(2021-01-15)
2021-01-15 - 司太立限售解禁特别提示(2021-01-14)
2021-01-14 - 司太立限售解禁特别提示(2021-01-13)
2021-01-13 - 司太立：主力机构活跃度动向解读
2021-01-12 - 司太立限售解禁特别提示(2021-01-12)
2021-01-12 - 北向资金动向曝光：“白酒双雄”双双被抛售超8亿元
2021-01-12 - 上海研诺获司太立增资 多个创新药将申报临床
2021-01-11 - 司太立：拟2000万元增资上海研诺获其8%股份 有
2021-01-11 - 司太立：拟出资2000万元投资上海研诺医药
2021-01-11 - 司太立限售解禁特别提示(2021-01-11)
2021-01-11
消息列表
| 一般消息 | 募资投向 | 公司购买资产 | 2021-01-12 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2020-12-10 |
| 一般消息 | 股东大会 | 临时股东大会 | 2020-12-08 |
| 一般消息 | 重大事项 | 关联交易 | 2020-11-26 |
| 一般消息 | 分红转增 | 不分配不转增 | 2020-08-28 |
| 利好 | 股票增发 | 已实施 | 2020-07-13 |
| 一般消息 | 重大事项 | 关联交易 | 2020-07-11 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2020-07-02 |
| 利空 | 重大事项 | 公司违规：处罚类型 | 2020-04-21 |
| 利好 | 分红转增 | 10转4股派3.5元(含税) | 2020-03-31 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 2条 | 0条 | 2条 |
| 利空 | 1条 | 0条 | 1条 |
行业面诊股
诊断结果：1.6行业面打败了8%的股票
化学制药行业最新资金流向
近10日来该行业走势总体向下，明显跑输大盘。
行业走势
近10日来该行业走势总体向下，明显跑输大盘。
[{"date":"2021.01.15","price":"0.01","value":"1.20"},{"date":"2021.01.14","price":"-0.91","value":"1.00"},{"date":"2021.01.13","price":"-0.27","value":"-2.33"},{"date":"2021.01.12","price":"2.18","value":"0.33"},{"date":"2021.01.11","price":"-1.08","value":"-2.00"},{"date":"2021.01.08","price":"-0.17","value":"-0.13"},{"date":"2021.01.07","price":"0.71","value":"-3.11"},{"date":"2021.01.06","price":"0.63","value":"-0.74"},{"date":"2021.01.05","price":"0.73","value":"0.33"},{"date":"2021.01.04","price":"0.86","value":"0.10"},{"date":"2020.12.31","price":"1.72","value":"1.35"},{"date":"2020.12.30","price":"1.05","value":"-0.35"},{"date":"2020.12.29","price":"-0.54","value":"-0.62"},{"date":"2020.12.28","price":"0.02","value":"-1.62"},{"date":"2020.12.25","price":"0.99","value":"0.28"},{"date":"2020.12.24","price":"-0.57","value":"-2.60"},{"date":"2020.12.23","price":"0.76","value":"-1.29"},{"date":"2020.12.22","price":"-1.86","value":"-0.71"},{"date":"2020.12.21","price":"0.76","value":"0.30"},{"date":"2020.12.18","price":"-0.29","value":"-1.49"},{"date":"2020.12.17","price":"1.13","value":"1.37"}]
上证指数,化学制药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 新和成 | 14.52% | 0.13% | 6.7分 |
| 2 | 药石科技 | 11.55% | -5.59% | 6.4分 |
| 3 | 贝达药业 | 10.15% | 13.78% | 6.6分 |
| 4 | 海正药业 | 8.85% | 1.54% | 5.3分 |
| 5 | 恒瑞医药 | 4.42% | -2.99% | 5.5分 |
| 6 | 博瑞医药 | 3.61% | -1.08% | 5.9分 |
| 8 | 信立泰 | 2.17% | 1.22% | 5.8分 |
| 10 | 司太立 | 1.50% | 12.25% | 6.1分 |
| 12 | 汉商集团 | -0.51% | -0.66% | 5.4分 |
| 14 | 华润双鹤 | -1.23% | 0.42% | 5.4分 |
| 16 | 普利制药 | -2.49% | -0.29% | 5.4分 |
| 18 | 亚太药业 | -3.38% | 13.41% | 5.4分 |
| 20 | 九典制药 | -3.78% | 9.68% | 5.7分 |
| 22 | 吉林敖东 | -4.41% | -1.03% | 4.6分 |
| 24 | 九洲药业 | -4.94% | 0.75% | 5.2分 |
| 26 | 博腾股份 | -5.55% | 6.11% | 4.8分 |
| 28 | 中关村 | -5.70% | 3.27% | 5.3分 |
| 30 | 海普瑞 | -6.27% | 1.36% | 5.8分 |
| 32 | 花园生物 | -6.85% | -3.65% | 4.1分 |
| 34 | 一品红 | -6.96% | -1.49% | 5.5分 |
| 36 | 海欣股份 | -7.58% | -5.18% | 4.1分 |
| 38 | 鲁抗医药 | -7.89% | -13.65% | 4.8分 |
| 40 | 哈药股份 | -8.10% | -5.14% | 4.8分 |
| 42 | 诚意药业 | -8.27% | 3.40% | 5.5分 |
| 44 | 微芯生物 | -8.47% | -2.44% | 5.0分 |
| 46 | 山大华特 | -8.73% | 0.73% | 5.6分 |
| 48 | 莱美药业 | -9.07% | 0.82% | 5.5分 |
| 50 | 海翔药业 | -9.63% | -2.72% | 4.6分 |
| 52 | 江苏吴中 | -9.91% | -4.10% | 4.7分 |
| 54 | 通化金马 | -10.22% | 6.71% | 5.5分 |
| 56 | 华东医药 | -10.44% | -4.70% | 5.4分 |
| 58 | 润都股份 | -10.73% | -1.64% | 5.4分 |
| 60 | 北大医药 | -11.25% | -5.04% | 5.1分 |
| 62 | 莎普爱思 | -11.46% | -5.08% | 4.6分 |
| 64 | 华北制药 | -11.77% | -3.32% | 4.9分 |
| 66 | 富祥药业 | -11.87% | 3.02% | 5.1分 |
| 68 | 神奇制药 | -12.10% | -3.49% | 5.2分 |
| 70 | 同和药业 | -12.37% | 10.25% | 5.6分 |
| 72 | *ST辅仁 | -12.89% | -6.46% | 4.7分 |
| 74 | 广济药业 | -13.26% | -4.32% | 4.9分 |
| 76 | ST天圣 | -13.66% | -0.48% | 4.4分 |
| 78 | 华邦健康 | -14.03% | -2.98% | 5.0分 |
| 80 | 人福医药 | -14.13% | -4.04% | 5.4分 |
| 82 | 健友股份 | -14.58% | -4.92% | 5.6分 |
| 84 | 尔康制药 | -14.69% | -4.19% | 4.5分 |
| 86 | 丰原药业 | -15.03% | -8.69% | 4.9分 |
| 88 | 昂利康 | -16.22% | -2.18% | 5.1分 |
| 90 | 仙琚制药 | -16.61% | -9.51% | 4.9分 |
| 92 | 海思科 | -17.57% | 0.00% | 5.6分 |
| 94 | 康芝药业 | -18.28% | -3.26% | 4.7分 |
| 96 | 哈三联 | -18.89% | -6.60% | 4.4分 |
| 98 | 灵康药业 | -19.36% | -8.38% | 4.5分 |
| 100 | 华海药业 | -19.91% | -8.05% | 5.3分 |
| 102 | 福安药业 | -20.14% | -5.26% | 4.5分 |
| 104 | 翰宇药业 | -20.27% | -1.19% | 5.1分 |
| 106 | 立方制药 | -20.42% | -4.41% | 5.3分 |
| 108 | 泽璟制药 | -20.58% | -1.91% | 4.2分 |
| 110 | 赛托生物 | -20.87% | -4.79% | 4.5分 |
| 112 | 振东制药 | -21.40% | -16.42% | 4.0分 |
| 114 | 海辰药业 | -21.99% | -6.05% | 4.9分 |
| 116 | 广生堂 | -23.90% | -7.68% | 4.4分 |
| 118 | 德展健康 | -30.49% | -1.43% | 5.2分 |
| 120 | 悦康药业 | - | -2.41% | 4.6分 |
行业评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 暂无相关评级 |
更多>>行业资讯
- 2012-02-17青岛：加快向“世界强港”转型新增万吨级泊位24个
- 2012-02-17江苏港口发展“四稳四进”
- 2012-02-17今年河北省重点打造综合性港口群
- 2012-02-16招商轮船：非公开发行A股股票申请获得中国证券监督管理委员会核准
- 2012-02-16泉州市今年将冲刺“亿吨大港”
- 2012-02-16大连市集装箱运输生产“逆市飘红”
- 2012-02-16江苏港口发展“四稳四进”
- 2012-02-16连云港港：绿色生态大港正向我们走来
- 2012-02-15靖江今年港口建设预投28亿元 完成港口货物吞吐量8000万吨
- 2012-02-15舟山“大港口”建设撬动群岛新区大盘
基本面诊股
[ 截止日期：2020-09-30 ]公司经营
盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 20/212 ， 78/212。
[{"date":"2020-09-30","value":"14.21","vol":"6.46"},{"date":"2020-06-30","value":"13.53","vol":"4.76"},{"date":"2020-03-31","value":"4.48","vol":"1.92"},{"date":"2019-12-31","value":"18.05","vol":"2.28"},{"date":"2019-09-30","value":"14.64","vol":"4.40"}]
| 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
14.21 | 13.53 | 4.48 | 18.05 | 14.64 |
| 行业(%) | 6.46 | 4.76 | 1.92 | 2.28 | 4.40 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2020-09-30","value":"46.49","vol":"54.90"},{"date":"2020-06-30","value":"47.41","vol":"53.37"},{"date":"2020-03-31","value":"45.27","vol":"52.33"},{"date":"2019-12-31","value":"42.72","vol":"53.69"},{"date":"2019-09-30","value":"42.01","vol":"53.33"}]
| 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
46.49 | 47.41 | 45.27 | 42.72 | 42.01 |
| 行业(%) | 54.90 | 53.37 | 52.33 | 53.69 | 53.33 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 40/212 ， 27/212。
[{"date":"2020-09-30","value":"6.16","vol":"-2.67"},{"date":"2020-06-30","value":"13.56","vol":"-6.16"},{"date":"2020-03-31","value":"-0.95","vol":"-11.39"},{"date":"2019-12-31","value":"46.98","vol":"17.94"},{"date":"2019-09-30","value":"55.43","vol":"10.79"}]
| 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
6.16 | 13.56 | -0.95 | 46.98 | 55.43 |
| 行业(%) | -2.67 | -6.16 | -11.39 | 17.94 | 10.79 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2020-09-30","value":"44.40","vol":"-89.17"},{"date":"2020-06-30","value":"50.00","vol":"79.45"},{"date":"2020-03-31","value":"11.83","vol":"-33.42"},{"date":"2019-12-31","value":"81.83","vol":"-46.86"},{"date":"2019-09-30","value":"62.08","vol":"144.46"}]
| 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
44.40 | 50.00 | 11.83 | 81.83 | 62.08 |
| 行业(%) | -89.17 | 79.45 | -33.42 | -46.86 | 144.46 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 94/212 ， 87/212。
[{"date":"2020-09-30","value":"0.27","vol":"0.39"},{"date":"2020-06-30","value":"0.20","vol":"0.26"},{"date":"2020-03-31","value":"0.08","vol":"0.11"},{"date":"2019-12-31","value":"0.40","vol":"0.63"},{"date":"2019-09-30","value":"0.30","vol":"0.42"}]
| 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.27 | 0.20 | 0.08 | 0.40 | 0.30 |
| 行业(次) | 0.39 | 0.26 | 0.11 | 0.63 | 0.42 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2020-09-30","value":"1.22","vol":"2.10"},{"date":"2020-06-30","value":"0.87","vol":"1.38"},{"date":"2020-03-31","value":"0.37","vol":"0.63"},{"date":"2019-12-31","value":"1.76","vol":"4.20"},{"date":"2019-09-30","value":"1.38","vol":"2.85"}]
| 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
1.22 | 0.87 | 0.37 | 1.76 | 1.38 |
| 行业(次) | 2.10 | 1.38 | 0.63 | 4.20 | 2.85 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2020-09-30","value":"2.17","vol":"-420.11"},{"date":"2020-06-30","value":"18.69","vol":"-171.56"},{"date":"2020-03-31","value":"3.64","vol":"-421.26"},{"date":"2019-12-31","value":"28.33","vol":"-744.81"},{"date":"2019-09-30","value":"22.66","vol":"-158.61"}]
| 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 2.17 | 18.69 | 3.64 | 28.33 | 22.66 |
| 行业 | -420.11 | -171.56 | -421.26 | -744.81 | -158.61 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2020-09-30","value":"","vol":"0.08"},{"date":"2020-06-30","value":"1.15","vol":"2.36"},{"date":"2020-03-31","value":"","vol":"0.02"},{"date":"2019-12-31","value":"1.19","vol":"2.69"},{"date":"2019-09-30","value":"","vol":"0.08"}]
| 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 1.15 | - | 1.19 | - |
| 行业 | 0.08 | 2.36 | 0.02 | 2.69 | 0.08 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 56/212 ， 11/212。
[{"date":"2020-09-30","value":"1.27","vol":"2.96"},{"date":"2020-06-30","value":"0.84","vol":"2.97"},{"date":"2020-03-31","value":"0.80","vol":"2.73"},{"date":"2019-12-31","value":"0.77","vol":"2.60"},{"date":"2019-09-30","value":"0.74","vol":"2.43"}]
| 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
1.27 | 0.84 | 0.80 | 0.77 | 0.74 |
| 行业 | 2.96 | 2.97 | 2.73 | 2.60 | 2.43 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2020-09-30","value":"0.92","vol":"2.35"},{"date":"2020-06-30","value":"0.57","vol":"2.36"},{"date":"2020-03-31","value":"0.52","vol":"2.07"},{"date":"2019-12-31","value":"0.49","vol":"1.94"},{"date":"2019-09-30","value":"0.48","vol":"1.65"}]
| 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
0.92 | 0.57 | 0.52 | 0.49 | 0.48 |
| 行业 | 2.35 | 2.36 | 2.07 | 1.94 | 1.65 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 24/212 ， 16/212。
[{"date":"2020-09-30","value":"57.52","vol":"34.25"},{"date":"2020-06-30","value":"70.84","vol":"35.21"},{"date":"2020-03-31","value":"69.75","vol":"35.20"},{"date":"2019-12-31","value":"70.48","vol":"36.07"},{"date":"2019-09-30","value":"70.02","vol":"32.33"}]
| 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
57.52 | 70.84 | 69.75 | 70.48 | 70.02 |
| 行业(%) | 34.25 | 35.21 | 35.20 | 36.07 | 32.33 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2020-09-30","value":"1.38","vol":"0.75"},{"date":"2020-06-30","value":"2.51","vol":"0.79"},{"date":"2020-03-31","value":"2.39","vol":"0.82"},{"date":"2019-12-31","value":"2.47","vol":"1.44"},{"date":"2019-09-30","value":"2.42","vol":"0.65"}]
| 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
1.38 | 2.51 | 2.39 | 2.47 | 2.42 |
| 行业(%) | 0.75 | 0.79 | 0.82 | 1.44 | 0.65 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信建投 | 2021-01-14 | 买入 | |
| 中泰证券 | 2020-12-13 | 买入 | 买入 |
| 平安证券 | 2020-10-30 | 增持 | |
| 华金证券 | 2020-10-30 | 买入 | |
| 华泰证券 | 2020-10-30 | 买入 | |
| 国盛证券 | 2020-10-29 | 买入 |
机构预测
机构预测该股2020年每股收益与前一年相同，长期投资价值一般。
[{"date":"2016","yellowRectValue":"0.76","blueLineValue":"","type":""},{"date":"2017","yellowRectValue":"0.83","blueLineValue":"","type":""},{"date":"2018","yellowRectValue":"0.94","blueLineValue":"","type":""},{"date":"2019","yellowRectValue":"1.70","blueLineValue":"","type":""},{"date":"2020","yellowRectValue":"2.65","blueLineValue":"1.08","type":"YC"}]